Bard® TigerTail™ Flexible Tip Ureteral Catheters 139004Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10801741127080), received between May 28, 2024 and May 28, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Material Fragmentation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryMay 28, 2024Material Fragmentation; Material Fragmentation

  IT WAS REPORTED THAT TIGERTAIL 4FR WAS USED FOR SURGERY ON THE RENAL PELVIS OF AN INFANT (1 AND A HALF YEARS OLD). DURING THE OPERATION, THE TIP OF THE TIGER TAIL (BLACK PART) WAS REMOVED AND REMAINED INSIDE THE INFANT'S BODY. THE OPERATION WAS COMPLETED WITH THE TIP REMAINING IN THE BODY DUE TO THE SEVERELY INVASIVE NATURE OF THE PROCEDURE. IT WILL BE REMOVED AT A LATER DATE. IT WAS UNKNOWN WHAT MEDICAL INTERVENTION WAS PROVIDED. PER ADDITIONAL INFORMATION RECEIVED VIA EMAIL ON 18MAY2024, IT WAS REPORTED THAT THE INVASIVENESS DID NOT BECOME MORE SEVERE AFTER USING TIGER TAIL, BUT THE ORIGINAL SURGERY ITSELF WAS HIGHLY INVASIVE.

  Patient problems: Foreign Body In Patient

  MAUDE report 19407932 ↗